Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Douglas Middleton Dahl, M.D.

Co-Author

This page shows the publications co-authored by Douglas Dahl and Michael Blute.
Connection Strength

0.732
  1. Combination MRI-targeted and systematic prostate biopsy may overestimate gleason grade on final surgical pathology and impact risk stratification. Urol Oncol. 2022 02; 40(2):59.e1-59.e5.
    View in: PubMed
    Score: 0.060
  2. Complications and Outcomes of Salvage Cystectomy after Trimodality Therapy. J Urol. 2021 Jul; 206(1):29-36.
    View in: PubMed
    Score: 0.058
  3. Long-term Oncologic Impact of Positive Anterior and Posterior Surgical Margins After Radical Prostatectomy. Am J Clin Oncol. 2020 12 01; 43(12):872-879.
    View in: PubMed
    Score: 0.057
  4. Impact of biopsy perineural invasion on younger prostate cancer patients after radical prostatectomy. Scand J Urol. 2020 Dec; 54(6):475-480.
    View in: PubMed
    Score: 0.056
  5. Clinicopathological characteristics of localized prostate cancer in younger men aged = 50 years treated with radical prostatectomy in the PSA era: A systematic review and meta-analysis. Cancer Med. 2020 09; 9(18):6473-6484.
    View in: PubMed
    Score: 0.055
  6. Quantification of perineural invasion focus after radical prostatectomy could improve predictive power of recurrence. Hum Pathol. 2020 10; 104:96-104.
    View in: PubMed
    Score: 0.055
  7. Multiparametric Magnetic Resonance Imaging-Ultrasound Fusion Biopsy Improves but Does Not Replace Standard Template Biopsy for the Detection of Prostate Cancer. J Urol. 2019 11; 202(5):944-951.
    View in: PubMed
    Score: 0.052
  8. Reply by Authors. J Urol. 2019 10; 202(4):821-822.
    View in: PubMed
    Score: 0.052
  9. Impact of biopsy perineural invasion on the outcomes of patients who underwent radical prostatectomy: a systematic review and meta-analysis. Scand J Urol. 2019 Oct; 53(5):287-294.
    View in: PubMed
    Score: 0.052
  10. Active Surveillance of Prostate Cancer is a Viable Option for Men Younger than 60 Years. J Urol. 2019 04; 201(4):721-727.
    View in: PubMed
    Score: 0.051
  11. Patient-reported Functional Outcomes Following Open, Laparoscopic, and Robotic Assisted Radical Prostatectomy Performed by High-volume Surgeons at High-volume Hospitals. Eur Urol Focus. 2016 Jun; 2(2):172-179.
    View in: PubMed
    Score: 0.039
  12. Active surveillance for low-risk prostate cancer: Need for intervention and survival at 10 years. Urol Oncol. 2015 Sep; 33(9):383.e9-16.
    View in: PubMed
    Score: 0.039
  13. Preoperative Anemia as an Independent Prognostic Indicator of Papillary Renal Cell Carcinoma. Clin Genitourin Cancer. 2015 Oct; 13(5):e353-60.
    View in: PubMed
    Score: 0.039
  14. Prognostic significance of indeterminate lung nodules in renal cell carcinoma. Urol Oncol. 2014 Apr; 32(3):355-61.
    View in: PubMed
    Score: 0.035
  15. Prognostic significance of indeterminate lung nodules in renal cell carcinoma. J Clin Oncol. 2013 Feb 20; 31(6_suppl):377.
    View in: PubMed
    Score: 0.033
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.